North America Leads the CNS Biomarker Market: R&D, Funding, and Infrastructure
Brain Breakthroughs: The Billion-Dollar Boom in Central Nervous System Biomarkers” April 2025 — In a major leap for neuroscience and precision medicine, Central Nervous System (CNS) biomarkers are emerging as the key to unlocking early diagnosis and personalized treatment for complex brain disorders. From Alzheimer’s to multiple sclerosis, these biological...
0 Комментарии 0 Поделились